Advertisement

Biochemistry (Moscow)

, Volume 77, Issue 1, pp 33–40 | Cite as

Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein

  • N. V. RavinEmail author
  • R. Y. Kotlyarov
  • E. S. Mardanova
  • V. V. Kuprianov
  • A. I. Migunov
  • L. A. Stepanova
  • L. M. Tsybalova
  • O. I. Kiselev
  • K. G. Skryabin
Article

Abstract

Conventional influenza vaccines are based on a virus obtained in chicken embryos or its components. The high variability of the surface proteins of influenza virus, hemagglutinin and neuraminidase, requires strain-specific vaccines matching the antigenic specificity of newly emerging virus strains to be developed. A recombinant vaccine based on a highly conservative influenza virus protein M2 fused to a nanosized carrier particle can be an attractive alternative to traditional vaccines. We have constructed a recombinant viral vector based on potato X virus that provides for expression in the Nicotiana benthamiana plants of a hybrid protein M2eHBc consisting of an extracellular domain of influenza virus M2 protein (M2e) fused to hepatitis B core antigen (HBc). This vector was introduced into plant cells by infiltrating leaves with agrobacteria carrying the viral vector. The hybrid protein M2eHBc was synthesized in the infected N. benthamiana plants in an amount reaching 1–2% of the total soluble protein and formed virus-like particles with the M2e peptide presented on the surface. Methods of isolation and purification of M2eHBc particles from plant producers were elaborated. Experiments on mice have shown a high immunogenicity of the plant-produced M2eHBc particles and their protective effect against lethal influenza challenge. The developed transient expression system can be used for production of M2e-based candidate influenza vaccine in plants.

Key words

influenza vaccine plant biofactories M2 protein HBc antigen viral vector virus-like particle 

Abbreviations

GFP

green fluorescent protein

HBc

hepatitis B virus nuclear antigen

LD50

the dose corresponding to 50% lethality

M2e

M2 protein extracellular domain of the influenza virus

PBS

phosphate-buffered saline

PXV

potato X virus

35S promoter

35S RNA promoter of the cauliflower mosaic virus

35S terminator

35S RNA terminator of the cauliflower mosaic virus

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nicholson, K., Webster, R., and Hay, A. (1998) Textbook of Influenza, Blackwell Science, Oxford.Google Scholar
  2. 2.
    Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., and Kawaoka, Y. (1992) Microbiol. Rev., 56, 152–179.PubMedGoogle Scholar
  3. 3.
    Kiselev, O. I. (2010) Biotekhnologiya, 2, 8–24.Google Scholar
  4. 4.
    Webby, R. J., Perez, D. R., Coleman, J. S., Guan, Y., Knight, J. H., Govorkova, E. A., McClain-Moss, L. R., Peiris, J. S., Rehg, J. E., Tuomanen, E. I., and Webster, R. G. (2004) Lancet, 363, 1099–1103.PubMedCrossRefGoogle Scholar
  5. 5.
    Fiers, W., De Filette, M., El Bakkouri, K., Schepens, B., Roose, K., Schotsaert, M., Birkett, A., and Saelens, X. (2009) Vaccine, 27, 6280–6283.PubMedCrossRefGoogle Scholar
  6. 6.
    Fiers, W., De Filette, M., Birkett, A., Neirynck, S., and Min Jou, W. (2004) Virus Res., 103, 173–176.PubMedCrossRefGoogle Scholar
  7. 7.
    Ito, T., Gorman, O. T., Kawaoka, Y., Bean, W. J., and Webster, R. G. (1991) J. Virol., 65, 5491–5498.PubMedGoogle Scholar
  8. 8.
    Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Jou, W. M., and Fiers, W. (1999) Nat. Med., 5, 1157–1163.PubMedCrossRefGoogle Scholar
  9. 9.
    Feng, J., Zhang, M., Mozdzanowska, K., Zharikova, D., Hoff, H., Wunner, W., Couch, R. B., and Gerhard, W. (2006) Virol. J., 3, 102.PubMedCrossRefGoogle Scholar
  10. 10.
    Clarke, B. E., Newton, S. E., Carroll, A. R., Francis, M. J., Appleyard, G., Syred, A. D., Highfield, P. E., Rowlands, D. J., and Brown, F. (1987) Nature, 330, 381–384.PubMedCrossRefGoogle Scholar
  11. 11.
    De Filette, M., Min Jou, W., Birkett, A., Lyons, K., Schultz, B., Tonkyro, A., Resch, S., and Fiers, W. (2005) Virology, 337, 149–161.PubMedCrossRefGoogle Scholar
  12. 12.
    Kotlyarov, R. Yu., Kupriyanov, V. V., Migunov, A. I., Stepanova, L. A., Tsybalova, L. M., Kiselev, O. I., Ravin, N. V., and Skryabin, K. G. (2010) Acta Naturae, 2, 75–80.Google Scholar
  13. 13.
    Ionescu, R. M., Przysiecki, C. T., Liang, X., Garsky, V. M., Fan, J., Wang, B., Troutman, R., Rippeon, Y., Flanagan, E., Shiver, J., and Shi, L. (2006) J. Pharm. Sci., 95, 70–79.PubMedCrossRefGoogle Scholar
  14. 14.
    Bessa, J., Schmitz, N., Hinton, H. J., Schwarz, K., Jegerlehner, A., and Bachmann, M. F. (2008) Eur. J. Immunol., 38, 114–126.PubMedCrossRefGoogle Scholar
  15. 15.
    Denis, J., Acosta-Ramirez, E., Zhao, Y., Hamelin, M. E., Koukavica, I., Baz, M., Abed, Y., Savard, C., Pare, C., Lopez Macias, C., Boivin, G., and Leclerc, D. (2008) Vaccine, 26, 3395–3403.PubMedCrossRefGoogle Scholar
  16. 16.
    Meshcheryakova, Y. A., Eldarov, M. A., Migunov, A. I., Stepanova, L. A., Repko, I. A., Kiselev, O. I., Lomonosov, D. P., and Skryabin, K. G. (2009) Mol. Biol. (Moscow), 43, 741–750.CrossRefGoogle Scholar
  17. 17.
    Horn, M. E., Woodard, S. L., and Howard, J. A. (2004) Plant Cell Rep., 22, 711–720.PubMedCrossRefGoogle Scholar
  18. 18.
    Gleba, Y., Klimyuk, V., and Marillonnet, S. (2007) Curr. Opin. Biotechnol., 18, 134–141.PubMedCrossRefGoogle Scholar
  19. 19.
    Kapila, J., De Rycke, R., van Montagu, M., and Angenon, G. (1997) Plant Sci., 122, 101–108.CrossRefGoogle Scholar
  20. 20.
    Marillonnet, S., Thoeringer, C., Kandzia, R., Klimyuk, V., and Gleba, Y. (2005) Nat. Biotechnol., 23, 718–723.PubMedCrossRefGoogle Scholar
  21. 21.
    Canizares, M. C., Nicholson, L., and Lomonossoff, G. P. (2005) Immunol. Cell Biol., 83, 263–270.PubMedCrossRefGoogle Scholar
  22. 22.
    Chichester, J. A., and Yusibov, V. (2007) Hum. Vaccines, 3, 146–149.CrossRefGoogle Scholar
  23. 23.
    Mett, V., Musiychuk, K., Bi, H., Farrance, C. E., Horsey, A., Ugulava, N., Shoji, Y., de la Rosa, P., Palmer, G. A., Rabindran, S., Streatfield, S. J., Boyers, A., Russell, M., Mann, A., Lambkin, R., Oxford, J. S., Schild, G. C., and Yusibov, V. (2008) Infl. Other Resp. Viruses, 2, 33–40.CrossRefGoogle Scholar
  24. 24.
    D’Aoust, M. A., Lavoie, P. O., Couture, M. M., Trepanier, S., Guay, J. M., Dargis, M., Mongrand, S., Landry, N., Ward, B. J., and Vezina, L. P. (2008) Plant Biotechnol. J., 6, 930–940.PubMedCrossRefGoogle Scholar
  25. 25.
    Mardanova, E. S., Kotlyarov, R. Y., and Ravin, N. V. (2009) Mol. Biol. (Moscow), 3, 568–371.Google Scholar
  26. 26.
    Cellar, N. A., Kuppannan, K., Langhorst, M. L., Ni, W., Xu, P., and Young, S. A. (2008) J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 861, 29–39.PubMedCrossRefGoogle Scholar
  27. 27.
    Huang, Z., Santi, L., LePore, K., Kilbourne, J., Arntzen, C. J., and Mason, H. S. (2006) Vaccine, 24, 2506–2513.PubMedCrossRefGoogle Scholar
  28. 28.
    Komarova, T. V., Skulachev, M. V., Zvereva, A. S., Shvarts, A. M., Dorokhov, Y. L., and Atabekov, I. G. (2006) Biochemistry (Moscow), 71, 846–850.CrossRefGoogle Scholar
  29. 29.
    Voinnet, O., Rivas, S., Mestre, P., and Baulcombe, D. (2003) Plant J., 33, 949–956.PubMedCrossRefGoogle Scholar
  30. 30.
    Burrell, C. J., MacKay, P., Greenaway, P. J., Hofschneider, P. H., and Murray, K. (1979) Nature, 279, 43–48.PubMedCrossRefGoogle Scholar
  31. 31.
    Clarke, B. E., Newton, S. E., Carroll, A. R., Francis, M. J., Appleyard, G., Syed, A. D., Highfield, P. E., Rowlands, D. J., and Brown, F. (1987) Nature, 330, 381–384.PubMedCrossRefGoogle Scholar
  32. 32.
    Hildich, C. M., Rogers, L. J., and Bishop, D. H. L. (1990) J. Gen. Virol., 71, 2755–2759.CrossRefGoogle Scholar
  33. 33.
    Tsuda, S., Yoshioka, K., Tanaka, T., Iwata, A., Yoshikawa, A., Watanabe, Y., and Okada, Y. (1998) Vox Sang., 74, 148–155.PubMedCrossRefGoogle Scholar
  34. 34.
    Mechtcheriakova, I. A., Eldarov, M. A., Nicholson, L., Shanks, M., Skryabin, K. G., and Lomonossoff, G. P. (2006) J. Virol. Meth., 131, 10–15.CrossRefGoogle Scholar
  35. 35.
    Chen, Q., He, J., Phoolcharoen, W., and Mason, H. S. (2011) Hum. Vaccin., 7, 331–338.PubMedCrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2012

Authors and Affiliations

  • N. V. Ravin
    • 1
    Email author
  • R. Y. Kotlyarov
    • 1
  • E. S. Mardanova
    • 1
  • V. V. Kuprianov
    • 1
  • A. I. Migunov
    • 2
  • L. A. Stepanova
    • 2
  • L. M. Tsybalova
    • 2
  • O. I. Kiselev
    • 2
  • K. G. Skryabin
    • 1
  1. 1.Centre “Bioengineering”Russian Academy of SciencesMoscowRussia
  2. 2.Research Institute of InfluenzaRussian Federation Ministry of Health and Social DevelopmentSt. PetersburgRussia

Personalised recommendations